LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 1 of 2: Cell count and normalized growth rate inhibition values. - Dataset (ID:20259)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol 1 Concentration | Small Mol 1 Conc Unit | Small Molecule 2 | Small Mol 2 Concentration | Small Mol 2 Conc Unit | Biological Replicate | Technical Replicate | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 0 | uM | 2 | 1 | 1843 | 4849 | 5129 | 0.9253 | ||
| BT-20 | 0 | uM | 0 | uM | 2 | 3 | 1843 | 4294 | 5162 | 0.7668 | ||
| BT-20 | Lapatinib | 5.7735 | uM | 0 | uM | 3 | 3 | 280 | 482 | 601 | 0.6349 | |
| BT-20 | 0 | uM | 0 | uM | 1 | 1 | 2751 | 4340 | 4757 | 0.7804 | ||
| BT-20 | Neratinib | 0.1235 | uM | 0 | uM | 3 | 2 | 280 | 628 | 588 | 1.1243 |